|
Project Detail:
The coronavirus disease (COVID-19) pandemic has enormous human and socioeconomic toll on the Indian population. The government and society are taking measures to contain the infection. Vaccination is a critical strategy to combat the formidable virus. India already commenced implementation of a national vaccination program since 16 January 2021. The proposed Responsive COVID-19 Vaccines for Recovery (RECOVER) Project under the Asia Pacific Vaccine Access Facility (APVAX) will provide the government with immediate and flexible financing to procure safe and effective vaccines to inoculate around 97 million people from priority population according to the government’s national deployment and vaccination plan.1 The indicative impact is universal access to good quality health care services achieved.2 The financing is expected to be $1.5 billion under rapid response component of the APVAX
The TA is estimated to cost $7,000,000, of which (i) $2,000,000 will be financed on a grant basis by ADB’s Technical Assistance Special Fund (TASF-other Sources) and (ii) $5,000,000 will be financed on a grant basis by the Japan Fund for Poverty Reduction and administered by ADB.
Note: Please Download Project Document attached to this Project for more information.
|
